Objectives:
- Summary and evaluation of current knowledge on the impact on patients' health of small and non- or little-repetitive doses (amounts) of radioactive, biological and/or chemical substances, as currently used in diagnostic imaging procedures;
- Development of recommendations and guidelines to drive scientific and technologic innovation to improve patient healthcare in medical imaging:
- Identification, if clinical studies are needed, and corresponding detailing of the studies;
- Involvement of people in legislative approval of these agents for human use.